Literature DB >> 22288594

Multifunctional CD4⁺ T cells in patients with American cutaneous leishmaniasis.

A B B Macedo1, J C Sánchez-Arcila, A O Schubach, S C F Mendonça, A Marins-Dos-Santos, M de Fatima Madeira, T Gagini, M I F Pimentel, P M De Luca.   

Abstract

Leishmaniasis is a group of important parasitic diseases affecting millions worldwide. To understand more clearly the quality of T helper type 1 (Th1) response stimulated after Leishmania infection, we applied a multiparametric flow cytometry protocol to evaluate multifunctional T cells induced by crude antigen extracts obtained from promastigotes of Leishmania braziliensis (LbAg) and Leishmania amazonensis (LaAg) in peripheral blood mononuclear cells from healed cutaneous leishmaniasis patients. Although no significant difference was detected in the percentage of total interferon (IFN)-γ-producing CD4(+) T cells induced by both antigens, multiparametric flow cytometry analysis revealed clear differences in the quality of Th1 responses. LbAg induced an important proportion of multifunctional CD4(+) T cells (28% of the total Th1 response evaluated), whereas LaAg induced predominantly single-positive cells (68%), and 57% of those were IFN-γ single-positives. Multifunctional CD4(+) T cells showed the highest mean fluorescence intensity (MFI) for the three Th1 cytokines assessed and MFIs for IFN-γ and interleukin-2 from those cells stimulated with LbAg were significantly higher than those obtained after LaAg stimulation. These major differences observed in the generation of multifunctional CD4(+) T cells suggest that the quality of the Th1 response induced by L. amazonensis antigens can be involved in the mechanisms responsible for the high susceptibility observed in L. amazonensis-infected individuals. Ultimately, our results call attention to the importance of studying a Th1 response regarding its quality, not just its magnitude, and indicate that this kind of evaluation might help understanding of the complex and diverse immunopathogenesis of American tegumentary leishmaniasis.
© 2011 The Authors. Clinical and Experimental Immunology © 2011 British Society for Immunology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22288594      PMCID: PMC3374283          DOI: 10.1111/j.1365-2249.2011.04536.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  62 in total

1.  Mucosal leishmaniasis patients display an activated inflammatory T-cell phenotype associated with a nonbalanced monocyte population.

Authors:  S T Gaze; W O Dutra; M Lessa; H Lessa; L H Guimarães; A R de Jesus; L P Carvalho; P Machado; E M Carvalho; K J Gollob
Journal:  Scand J Immunol       Date:  2006-01       Impact factor: 3.487

Review 2.  New world cutaneous leishmaniasis in travellers.

Authors:  Eli Schwartz; Cristoph Hatz; Johannes Blum
Journal:  Lancet Infect Dis       Date:  2006-06       Impact factor: 25.071

3.  In vitro responses of human peripheral blood mononuclear cells to whole-cell, particulate and soluble extracts of Leishmania promastigotes.

Authors:  E Telino; P M De Luca; D C S Matos; R B Azeredo-Coutinho; M N Meirelles; F Conceição-Silva; A Schubach; S C F Mendonça
Journal:  Clin Exp Immunol       Date:  2006-02       Impact factor: 4.330

4.  Decreased in situ expression of interleukin-10 receptor is correlated with the exacerbated inflammatory and cytotoxic responses observed in mucosal leishmaniasis.

Authors:  Daniela R Faria; Kenneth J Gollob; José Barbosa; Albert Schriefer; Paulo R L Machado; Hélio Lessa; Lucas P Carvalho; Marco Aurélio Romano-Silva; Amélia R de Jesus; Edgar M Carvalho; Walderez O Dutra
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

5.  Preferential loss of IL-2-secreting CD4+ T helper cells in chronic HCV infection.

Authors:  Nasser Semmo; Cheryl L Day; Scott M Ward; Michaela Lucas; Gillian Harcourt; Andrew Loughry; Paul Klenerman
Journal:  Hepatology       Date:  2005-05       Impact factor: 17.425

6.  TGF-beta-associated enhanced susceptibility to leishmaniasis following intramuscular vaccination of mice with Leishmania amazonensis antigens.

Authors:  Roberta Olmo Pinheiro; Eduardo Fonseca Pinto; Janaina Ribeiro Correia Lopes; Herbert Leonel Matos Guedes; Regina Ferro Fentanes; Bartira Rossi-Bergmann
Journal:  Microbes Infect       Date:  2005-06-13       Impact factor: 2.700

7.  A randomized double-blind placebo-controlled trial to evaluate the immunogenicity of a candidate vaccine against American tegumentary leishmaniasis.

Authors:  P M De Luca; W Mayrink; J A Pinto; S G Coutinho; M A Santiago; V P Toledo; C A Costa; O Genaro; A B Reis; S C Mendonça
Journal:  Acta Trop       Date:  2001-12-21       Impact factor: 3.112

8.  Protective immunity using recombinant human IL-12 and alum as adjuvants in a primate model of cutaneous leishmaniasis.

Authors:  R T Kenney; D L Sacks; J P Sypek; L Vilela; A A Gam; K Evans-Davis
Journal:  J Immunol       Date:  1999-10-15       Impact factor: 5.422

9.  Leishmania amazonensis: participation of regulatory T and B cells in the in vitro priming (PIV) of CBA/J spleen cells susceptible response.

Authors:  Patrícia Sampaio Tavares Veras; Marcus Welby-Borges; Cláudia Dias de Santana; Jorge Nihei; Fabiola Cardillo; Luiz Antônio Rodrigues de Freitas
Journal:  Exp Parasitol       Date:  2006-03-03       Impact factor: 2.011

10.  Maintenance of HIV-specific CD4+ T cell help distinguishes HIV-2 from HIV-1 infection.

Authors:  Melody G Duvall; Assan Jaye; Tao Dong; Jason M Brenchley; Abraham S Alabi; David J Jeffries; Marianne van der Sande; Toyin O Togun; Samuel J McConkey; Daniel C Douek; Andrew J McMichael; Hilton C Whittle; Richard A Koup; Sarah L Rowland-Jones
Journal:  J Immunol       Date:  2006-06-01       Impact factor: 5.422

View more
  18 in total

Review 1.  Immunopathogenesis of non-healing American cutaneous leishmaniasis and progressive visceral leishmaniasis.

Authors:  Lynn Soong; Calvin A Henard; Peter C Melby
Journal:  Semin Immunopathol       Date:  2012-10-11       Impact factor: 9.623

Review 2.  Dynamic balance of pro- and anti-inflammatory signals controls disease and limits pathology.

Authors:  Joseph M Cicchese; Stephanie Evans; Caitlin Hult; Louis R Joslyn; Timothy Wessler; Jess A Millar; Simeone Marino; Nicholas A Cilfone; Joshua T Mattila; Jennifer J Linderman; Denise E Kirschner
Journal:  Immunol Rev       Date:  2018-09       Impact factor: 12.988

3.  Attenuated and replication-competent vaccinia virus strains M65 and M101 with distinct biology and immunogenicity as potential vaccine candidates against pathogens.

Authors:  Lucas Sánchez-Sampedro; Carmen Elena Gómez; Ernesto Mejías-Pérez; Eva Pérez-Jiménez; Juan Carlos Oliveros; Mariano Esteban
Journal:  J Virol       Date:  2013-04-17       Impact factor: 5.103

4.  American tegumentary leishmaniasis: T-cell differentiation profile of cutaneous and mucosal forms-co-infection with Trypanosoma cruzi.

Authors:  Cecilia Parodi; María F García Bustos; Alejandra Barrio; Federico Ramos; Ana G González Prieto; María C Mora; Patricia Baré; Miguel A Basombrío; María M de Elizalde de Bracco
Journal:  Med Microbiol Immunol       Date:  2016-04-04       Impact factor: 3.402

5.  Comparison of Lethal and Nonlethal Mouse Models of Orientia tsutsugamushi Infection Reveals T-Cell Population-Associated Cytokine Signatures Correlated with Lethality and Protection.

Authors:  Alison Luce-Fedrow; Suchismita Chattopadhyay; Teik-Chye Chan; Gregory Pearson; John B Patton; Allen L Richards
Journal:  Trop Med Infect Dis       Date:  2021-07-02

6.  High quality long-term CD4+ and CD8+ effector memory populations stimulated by DNA-LACK/MVA-LACK regimen in Leishmania major BALB/c model of infection.

Authors:  Lucas Sánchez-Sampedro; Carmen Elena Gómez; Ernesto Mejías-Pérez; Carlos Oscar S Sorzano; Mariano Esteban
Journal:  PLoS One       Date:  2012-06-08       Impact factor: 3.240

7.  Interferon gamma in leishmaniasis.

Authors:  Peter E Kima; Lynn Soong
Journal:  Front Immunol       Date:  2013-06-19       Impact factor: 7.561

8.  Vaccine Development Against Leishmania donovani.

Authors:  Amrita Das; Nahid Ali
Journal:  Front Immunol       Date:  2012-05-15       Impact factor: 7.561

9.  Insulin-like growth factor-I induces arginase activity in Leishmania amazonensis amastigote-infected macrophages through a cytokine-independent mechanism.

Authors:  Celia Maria Vieira Vendrame; Marcia Dias Teixeira Carvalho; Andre Gustavo Tempone; Hiro Goto
Journal:  Mediators Inflamm       Date:  2014-09-09       Impact factor: 4.711

10.  Targeting Leishmania major Antigens to Dendritic Cells In Vivo Induces Protective Immunity.

Authors:  Ines Matos; Olga Mizenina; Ashira Lubkin; Ralph M Steinman; Juliana Idoyaga
Journal:  PLoS One       Date:  2013-06-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.